A detailed history of Goldstone Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Goldstone Financial Group, LLC holds 420 shares of LLY stock, worth $366,945. This represents 0.05% of its overall portfolio holdings.

Number of Shares
420
Previous 293 43.34%
Holding current value
$366,945
Previous $260 Million 24.85%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$727.2 - $932.06 $92,354 - $118,371
127 Added 43.34%
420 $324 Million
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $226,237 - $281,285
293 New
293 $260 Million
Q2 2024

Jan 15, 2025

BUY
$724.87 - $909.04 $22,470 - $28,180
31 Added 7.38%
451 $408 Million
Q1 2024

Jan 15, 2025

BUY
$592.2 - $792.28 $5,922 - $7,922
10 Added 2.83%
363 $282 Million
Q4 2023

Jan 15, 2025

SELL
$525.19 - $619.13 $35,187 - $41,481
-67 Reduced 15.95%
353 $206 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $830B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Goldstone Financial Group, LLC Portfolio

Follow Goldstone Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldstone Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goldstone Financial Group, LLC with notifications on news.